Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Discontinued Operations Cash from Discontinued Operations Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Novanta (NOVT) Capital Expenditures (2016 - 2026)

Novanta filings provide 17 years of Capital Expenditures readings, the most recent being $4.1 million for Q2 2026.

On a quarterly basis, Capital Expenditures fell 3.41% to $4.1 million in Q2 2026 year-over-year; TTM through Apr 2026 was $1.0 million, a 152.26% increase, with the full-year FY2025 number at $1.2 million, down 54.53% from a year prior.
Capital Expenditures hit $4.1 million in Q2 2026 for Novanta, up from -$10.8 million in the prior quarter.
In the past five years, Capital Expenditures ranged from a high of $6.8 million in Q3 2023 to a low of -$13.7 million in Q4 2022.
Median Capital Expenditures over the past 5 years was $3.6 million (2023), compared with a mean of $592235.3.
Biggest five-year swings in Capital Expenditures: skyrocketed 107.04% in 2023 and later plummeted 47.59% in 2024.
Novanta's Capital Expenditures stood at -$13.7 million in 2022, then grew by 3.89% to -$13.2 million in 2023, then rose by 5.98% to -$12.4 million in 2024, then rose by 12.75% to -$10.8 million in 2025, then skyrocketed by 138.3% to $4.1 million in 2026.
The last three reported values for Capital Expenditures were $4.1 million (Q2 2026), -$10.8 million (Q4 2025), and $4.3 million (Q3 2025) per Business Quant data.